0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2004;292(11):1269. doi:10.1001/jama.292.11.1269.
Text Size: A A A
Published online

EXPRESS

De Lemos and colleaguesArticlereport results of a randomized trial of patients following an acute coronary syndrome (ACS). The trial compares early initiation of intensive simvastatin therapy (80 mg/d) vs delayed initiation of 20-mg/d simvastatin on a composite end point of cardiovascular death, nonfatal myocardial infarction, readmission for ACS, or stroke. In the initial 4 months of follow-up, there was no significant difference in outcomes between the 2 groups. After 4 months, there was a trend toward reduced major cardiovascular events in the early intensive statin therapy group although with a higher risk of myopathy. In an editorial,ArticleNissen discusses reasons intensive therapy did not demonstrate early benefit in this trial and urges caution in prescribing 80-mg/d simvastatin.

BREAST SURVEILLANCE IN

Women with a BRCA1 or BRCA2 mutation are advised to have annual mammograms and biennial clinical breast examinations (CBEs), but when detected, many of their tumors are advanced stage. Whether breast magnetic resonance imaging (MRI) or ultrasound would improve tumor detection is not known. In a cohort of women with BRCA mutations, Warner and colleaguesArticleassessed the individual sensitivity and specificity of annual mammography, ultrasound, and MRI and biennial CBE and the sensitivity of performing all 4 screening modalities vs the combination of mammography and CBE. Twenty-two cancers were detected in the study of 236 women. Of these, 17 were detected by MRI (7 by MRI alone), 8 by mammography, 7 by ultrasound, and 2 by CBE. Sensitivity was 95% for all 4 modalities combined vs 45% for mammography and CBE. In an editorial,ArticleRobson and Offit discuss the potential value of MRI for breast cancer surveillance.

Β-BLOCKERS AND RISK OF FRACTURE

In animal studies, the β-blocker propranolol increases bone formation, but whether a similar effect is seen in humans is not known. In a case-control study, Schlienger and colleagues assessed the risk of fracture in patients taking β-blockers alone or in combination with thiazides. They found fracture risk was significantly reduced in patients currently taking β-blockers or thiazides, alone or in combination, compared with patients who did not take either drug.

INFLUENZA-ASSOCIATED HOSPITALIZATIONS

To provide estimates of influenza severity, Thompson and colleagues analyzed national hospital discharge and influenza surveillance data to determine influenza-associated hospitalizations in the United States from 1979-1980 through 2000-2001. Overall, the numbers and rates of influenza-associated hospitalizations increased over the study period. The highest rates were for persons 85 years or older and the lowest rates for persons aged 5 through 49 years. Rates for children younger than 5 years were similar to those for persons aged 50 to 64 years.

MEDICAL NEWS & PERSPECTIVES

Researchers are finding that aspects of the fetal environment, such as maternal nutrition and stress, may have important long-term consequences for health. (Photo credit: Rubèn Quintero, MD

GENETICS OF LONG QT SYNDROME

Genetic variants of long QT syndrome predict cardiac events in patients taking β-blockers.

DEMENTIA AND VOTING

Issues surrounding voting by persons with dementia.

CLINICIAN'S CORNER

Clinical Crossroads
Knight discusses substance abuse by physicians, the role of colleagues, and treatment options.

CLINICAL TRIAL REGISTRATION

Recent developments in efforts to require clinical trial registration and achieve wider dissemination of trial data.

JAMA PATIENT PAGE

For your patients: Information about opioid abuse.

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.